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Abstract 
Portal hypertension commonly arises in the setting of advanced liver cirrhosis and is the con-
sequence of increased resistance within the portal vasculature. Less commonly, left-sided 
noncirrhotic portal hypertension can develop in a patient secondary to isolated obstruction 
of the splenic vein. We present a rare case of left-sided portal hypertension and isolated 
gastric varices in a patient with large B-cell lymphoma, who was treated with splenic artery 
embolization. The patient is a 73-year-old male with no previous history of liver disease, who 
presented with coffee ground emesis and melena. On admission to hospital, he was found to 
have a hemoglobin level of 3.4 g/l. Emergent esophagogastroduodenoscopy showed isolat-
ed bleeding gastric varices (IGV1 by Sarin classification) in the fundus and cardia with subse-
quent argon plasma coagulation injection. He was transferred to our tertiary center where 
work-up revealed normal liver function tests, and abdominal ultrasound showed patent he-
patic/portal vasculature without cirrhosis. MRI demonstrated a large heterogeneously en-
hancing mass in the pancreatic tail, with invasion into the spleen and associated splenic vein 
thrombosis. Surgery consultation was obtained, but urgent splenectomy was not recom-
mended. The patient instead underwent splenic artery embolization to prevent future bleed-
ing from his known gastric varices. Pathology from a CT-guided biopsy was consistent with 
diffuse large B-cell lymphoma. PET imaging showed uptake in the splenic hilum/pancreatic 
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tail region with no additional metastatic involvement. He was evaluated by the Hematology 
Department to initiate R-CHOP chemotherapy. During his outpatient follow-up, he reported 
no further episodes of melena or hematemesis. To the best of our knowledge, there have 
only been two published case reports of large B-cell lymphoma causing upper gastrointesti-
nal bleeding from isolated gastric varices. These cases were treated with splenectomy or 
chemotherapy alone. Thus far, splenectomy has been the standard treatment approach for 
splenic vein thrombosis with clinical complication, such as gastric variceal bleeding. We pre-
sent a case of successful treatment of bleeding isolated gastric varices using a less invasive 
and less morbid approach through splenic artery embolization. This case highlights the need 
for an increased awareness of the diverse etiologies of left-sided portal hypertension and 
isolated gastric varices, as well as the consideration of minimally invasive management strat-
egies. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Portal hypertension commonly arises in the setting of advanced cirrhosis and is the di-
rect consequence of increased resistance within the portal vasculature. This process can be 
complicated by the development of ascites and gastroesophageal varices, among other com-
plications. Less commonly, portal hypertension can arise in a noncirrhotic patient secondary 
to obstruction of the splenic vein [1]. This phenomenon, known as left-sided portal hyper-
tension (LSPH), is a rare clinical syndrome, which may result in the formation of isolated 
gastric varices (IGV). After the splenic vein becomes occluded, blood drains through the 
short gastric veins at increased pressures, resulting in dilation of submucosal structures and 
the formation of IGV [1]. These varices have the potential to rupture and subsequently result 
in significant gastrointestinal (GI) hemorrhage. 
Although it comprises less than 5% of all cases of portal hypertension, the incidence of 
LSPH has been increasing over the past several decades, likely secondary to an increased 
awareness of its existence [1, 2]. Consequently, IGV due to LSPH should be considered in the 
differential diagnosis of patients presenting with upper GI bleeding, despite having normal 
liver function. The splenic vein obstruction or thrombosis that results in LSPH is usually seen 
in association with pancreatic disorders, secondary to the close anatomic relationship be-
tween the splenic vasculature and the pancreas [1]. Nonpancreatic etiologies of LSPH have 
been reported in the literature, but are much less common [1–3]. Splenectomy is currently 
the gold standard of treatment for bleeding IGV; however, less invasive alternatives, such as 
transcatheter splenic artery embolization are currently being explored. We present a rare 
case of LSPH and IGV in a patient with large B-cell lymphoma, who was ultimately treated 
with splenic artery embolization. 
Case 
The patient is a 73-year-old male with a past medical history of hyperlipidemia, hyper-
tension, and obstructive sleep apnea who originally presented to hospital with a 3-day histo-
ry of coffee ground emesis and melena. He also reported associated symptoms of dizziness, 
weakness, palpitations, and fatigue. In the Emergency Department, he was initially found to 
be hypotensive and tachycardic, with a hemoglobin level of 3.4 g/dl and an international 
normalized ratio of 1.29. He was aggressively resuscitated and transfused multiple units of 
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packed red blood cells with appropriate response. Emergent esophagogastroduodenoscopy 
(EGD) was performed showing isolated bleeding varices (IGV) in the gastric fundus and was 
subsequently treated with argon plasma coagulation. The patient was then started on intra-
venous protonix and octreotide drips and transferred to our tertiary care center for evalua-
tion of suspected underlying cirrhosis and for possible transjugular intrahepatic portosys-
temic shunt procedure. 
The patient denied any previous history of liver disease, injection drug use, or current 
alcohol use. However, he did admit to having one previous episode of hematemesis over 40 
years ago, which required blood transfusion. Upon further questioning, he also reported 
significant weight loss, with his weight decreasing from 318 to 280 pounds over a 6-month 
period. He underwent repeat EGD at our hospital, which again demonstrated multiple clus-
ters of medium-sized IGV (IGV1 by Sarin Classification) (fig. 1). Further work-up revealed 
normal liver function tests, and HIV/hepatitis screening was negative. Abdominal ultrasound 
showed patent hepatic and portal vasculature with no ultrasonographic evidence of cirrho-
sis. MRI and CT imaging demonstrated a large heterogeneously enhancing mass in the pan-
creatic tail with direct invasion into the spleen. There was also evidence of splenic vein 
thrombosis and enlarged abdominal lymph nodes. No metastatic disease was visualized in 
the liver or thorax (fig. 2; the arrow is pointing to the perisplenic mass). Because of his com-
bined clinical history and abnormal findings on imaging, there was initial concern for pan-
creatic malignancy, and he subsequently underwent CT-guided biopsy of the perisplenic 
mass. Surgery consultation was obtained to address possible resection of the mass to control 
the variceal bleed. However, given the patient’s high likelihood of significant morbidity with 
surgical intervention, urgent splenectomy was not recommended. Rather, the patient un-
derwent IR-guided splenic artery embolization to prevent future bleeding from his known 
gastric varices. He was discharged in stable condition with outpatient follow-up. 
Pathology of the perisplenic mass was consistent with stage IVA-E diffuse large B-cell 
lymphoma (fig. 3; pathology slide with hematoxylin and eosin staining). Immunohistochemi-
cal staining was positive for CD20, CD45, CD10, BCL6, and BCL2, and negative for CK19, CD3, 
CD5, cyclin D1, TTF-1, and TdT. MIB1 staining showed a proliferation rate of follicular struc-
tures up to 30%. PET-CT revealed intense fluorodeoxyglucose uptake within the known ab-
dominal mass, with no additional metastatic involvement. The patient was evaluated by the 
Hematology Department to initiate R-CHOP chemotherapy. He reported no further episodes 
of melena or hematemesis during his follow-up appointments.  
Discussion 
As stated previously, LSPH is an uncommon clinical condition, which may result in the 
formation of IGV. LSPH typically results from obstruction of the splenic vein, which can occur 
with thrombosis or mass effect from adjacent structures. Many cases of IGV are discovered 
incidentally; however, rupture of these varices can also present as GI bleeding in the form of 
melena or hematemesis. The incidence of upper GI bleeding in patients with LSPH ranges 
from 45 to 72% in reported studies [1–3]. Our particular patient presented with gastric vari-
ceal bleeding in the form of coffee ground emesis and melena. 
Pancreatic disorders account for the majority of cases of LSPH, secondary to the location 
of the splenic vein posterior to the pancreas. Acute and chronic pancreatitis, followed by 
pancreatic malignancies (adenocarcinomas, islet cell carcinomas, and cystadenomas), are 
among the most commonly reported causes of LSPH and IGV. Other pancreatic etiologies, 
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such as pseudocysts, abscesses, and pancreas divisum, have also been reported in the litera-
ture [1–3]. Nonpancreatic etiologies of LSPH are less common but include metastatic malig-
nancies (small cell lung cancer, renal cancer, gastric cancer, and colonic adenocarcinoma), 
lymphoma, surgical manipulations, retroperitoneal fibrosis, hypercoagulability disorders, 
and splenic artery aneurysms [1]. A diagnosis of LSPH is based on clinical history, radio-
graphic imaging, and findings on upper endoscopy. Although somewhat invasive, angi-
ography can also show filling deficits in the splenic vasculature and be used to confirm 
splenic vein thrombosis [1]. Endoscopic ultrasound has been shown to be superior to ab-
dominal ultrasound for assessing the patency of the portal vasculature and should be con-
sidered when other diagnostic methods have failed to confirm the cause of bleeding gastric 
varices [1, 4]. Contrast-enhanced CT venography and MR angiography with gadopentetate 
dimeglumine have also occasionally been used to aid in diagnosis [5, 6]. 
Mortality from gastric variceal bleeds has been reported to be as high as 52% at 1 year, 
due to the limited efficacy of endoscopic therapy and the high rate of recurrent bleeding [1, 
7]. Various options have been used to treat the bleeding from gastric varices, including en-
doscopic injection sclerotherapy, band ligation, and balloon-occluded retrograde trans-
venous obliteration, as well as injection of cyanoacrylate glue [1]. There are, however, more 
definitive treatment options for symptomatic patients with LSPH outside of endoscopic 
therapy. 
Splenectomy is currently the gold standard of treatment for IGV secondary to LSPH from 
either pancreatic or nonpancreatic processes. Surgical removal of the spleen decreases ve-
nous outflow through collateral circulations and decompresses IGV to prevent future bleed-
ing [8]. To the best of our knowledge, there have only been two other published case reports 
of large B-cell lymphoma causing upper GI bleeding from IGV [9, 10]. These cases were treat-
ed with splenectomy or chemotherapy alone. However, surgical splenectomy poses certain 
operative risks, especially in patients with multiple preexisting comorbidities. These risks 
include infection with encapsulated organisms, intra- and postoperative hemorrhage, 
thrombocytosis, pancreatitis, and gastric fistula formation, with reported morbidities and 
mortalities ranging from 8 to 52% and from 0 to 9%, respectively [11, 12]. One previous case 
report suggested that surgery might have been avoided in at least one case if the diagnosis of 
lymphoma had been considered preoperatively [9]. This illustrates the importance of recog-
nizing the etiology of LSPH and considering less invasive management strategies when pos-
sible. 
Transcatheter splenic artery embolization represents one of the less invasive alterna-
tives to splenectomy as a treatment option for IGV, and it has been used with various de-
grees of success [1, 13]. During this procedure, a catheter is passed through the splenic ar-
tery near the splenic hilum, and coils are deployed to occlude arterial blood supply to the 
spleen. This subsequently decreases venous return, lowers portal pressure within the vari-
ceal collateral vessels, and ultimately prevents future bleeding from IGV. Splenic artery em-
bolization has been shown to be as effective as splenectomy in lowering portal pressure and 
avoids potential complications of postsplenectomy sepsis or unregulated thrombocytosis. 
Studies have reported that the overall complication rate of splenic artery embolization is 
around 33–52% [14, 15]. However, most of these complications are minor and include 
symptoms of fever, leukocytosis, abdominal pain, and hydrothorax. More severe complica-
tions are rare, including splenic abscesses and splenic infarction [14, 15]. Our patient was 
able to undergo successful treatment with splenic artery embolization, thus avoiding the 
potential risks of surgery, and had cessation of his variceal bleeding. 
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Proximal portal decompressive procedures, such as transjugular intrahepatic portosys-
temic shunt, which are standard therapies in appropriate patients with liver cirrhosis and 
high portal pressures, do not have a role in the treatment of patients with isolated LSPH who 
typically are not cirrhotic and have normal portal pressures [1]. Recognizing this distinction 
emphasizes the importance of careful clinical evaluation for the cause of upper GI bleeding. 
Accurate diagnosis can help determine the safest and most effective approach to individual-
ized therapy, thereby improving clinical outcomes. 
Conclusion 
We present a case of successful treatment of bleeding IGV using a less invasive and less 
morbid approach through splenic artery embolization. This case highlights the need for an 
increased awareness of the diverse etiologies of LSPH and IGV, and the importance of accu-
rate diagnosis of the cause of bleeding in these patients. In many cases, a nonsurgical ap-
proach can offer equally effective treatment with less morbidity. 
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Fig. 1. EGD showing IGV 48 h after endoscopic therapy. 
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Fig. 2. MRI showing a mass in the pancreatic tail (arrow) with direct invasion into the spleen and associat-
ed splenic vein thrombosis. 
 
 
 
Fig. 3. Pathology slide with hematoxylin and eosin stain, consistent with diffuse large B-cell lymphoma. 
 
